(3R)-3-[4-[3-[4-(piperidin-1-ylmethyl)phenyl]phenyl]triazol-1-yl]-1-azabicyclo[2.2.2]octane
C27H33N5 — CID 155546523
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3R)-3-[4-[3-[4-(piperidin-1-ylmethyl)phenyl]phenyl]triazol-1-yl]-1-azabicyclo[2.2.2]octane
(3R)-3-[4-[3-[4-(piperidin-1-ylmethyl)phenyl]phenyl]triazol-1-yl]-1-azabicyclo[2.2.2]octane (PubChem CID 155546523) has the molecular formula C27H33N5 and a molecular weight of 427.60 g/mol. Its IUPAC name is (3R)-3-[4-[3-[4-(piperidin-1-ylmethyl)phenyl]phenyl]triazol-1-yl]-1-azabicyclo[2.2.2]octane.
Molecular Properties
| Compound Name | (3R)-3-[4-[3-[4-(piperidin-1-ylmethyl)phenyl]phenyl]triazol-1-yl]-1-azabicyclo[2.2.2]octane |
|---|---|
| PubChem CID | 155546523 |
| Molecular Formula | C27H33N5 |
| Molecular Weight | 427.60 g/mol |
| Exact Mass | 427.27 |
| IUPAC Name | (3R)-3-[4-[3-[4-(piperidin-1-ylmethyl)phenyl]phenyl]triazol-1-yl]-1-azabicyclo[2.2.2]octane |
| SMILES | c1cc(-c2ccc(CN3CCCCC3)cc2)cc(-c2cn([C@H]3CN4CCC3CC4)nn2)c1 |
| InChI | InChI=1S/C27H33N5/c1-2-13-30(14-3-1)18-21-7-9-22(10-8-21)24-5-4-6-25(17-24)26-19-32(29-28-26)27-20-31-15-11-23(27)12-16-31/h4-10,17,19,23,27H,1-3,11-16,18,20H2/t27-/m0/s1 |
| InChIKey | WTHPCHMVEFTNPJ-MHZLTWQESA-N |
| XLogP | 4.86 |
| TPSA | 37.19 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 427.60 |
| LogP ≤ 5 | 4.86 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155546523 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.